Sunshine Biopharma (SBFM) Stock Price, Quote & News

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pa...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 954 330 0684

Website: sunshinebiopharma.com

Address:

333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States

Masterrunner May. 14 at 12:35 AM

$SBFM Bulls talking this shit up; while it was going to down to oblivion.

0 · Reply

Tabi04 May. 14 at 12:25 AM

$SBFM well it’s right about buying time to play small game.

0 · Reply

hotslots May. 14 at 12:16 AM

$SBFM almost at 50 cents!

0 · Reply

Jimesica May. 13 at 11:45 PM

$SBFM woof, sales went down? WTF, well hopefully the good doctor lives to 120 so we can finally see his work make it to market. Maybe my grandkids will get my original investment back 🤷🏼

1 · Reply

hotslots May. 13 at 11:19 PM

$SBFM question for the smarter folks than me. Where do you think those volume spikes came from a couple times the past week or so? Was it buyers that thought there was an honest chance of success here?

0 · Reply

MB66 May. 13 at 10:07 PM

$SBFM earnings report is out, but chances are they won’t PR the dilution or the earnings report. I don’t even know why there is a board of directors or “management“ at this company.

0 · Reply

MB66 May. 13 at 9:59 PM

$SBFM https://www.sec.gov/ix?doc=/Archives/edgar/data/0001402328/000168316826003819/sunshine_i10q-033126.htm

0 · Reply

MS121 May. 13 at 9:47 PM

$SBFM Please just delist this trash already.

0 · Reply

RonRon1234 May. 13 at 9:46 PM

$SBFM at least we got volume hahahah rofl. Lol. Fuck this is trash.

0 · Reply

Nuisance May. 13 at 9:30 PM

$SBFM pure manipulation https://www.stocktitan.net/sec-filings/SBFM/10-q-sunshine-biopharma-inc-quarterly-earnings-report-286cc9f11cc0.html

0 · Reply

Sunshine Biopharma files to sell 5.825M common units

2026-04-06T12:53:12.000Z - 5 weeks ago

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

2026-04-06T12:52:43.000Z - 5 weeks ago

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

Apr 6, 2026, 8:30 AM EDT - 5 weeks ago

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Oct 28, 2025, 2:10 PM EDT - 7 months ago

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

2025-10-28T11:50:45.000Z - 7 months ago

Sunshine Biopharma’s Nora Pharma receives Health Canada approval for domperidone

Oct 28, 2025, 7:45 AM EDT - 7 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

2025-10-20T11:50:37.000Z - 7 months ago

Sunshine Biopharma announces commercial launch of doxycycline in Canada

Oct 20, 2025, 7:45 AM EDT - 7 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

2025-10-16T11:50:20.000Z - 7 months ago

Sunshine Biopharma’s Nora Pharma launches pravastatin

Oct 16, 2025, 7:45 AM EDT - 7 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025, 10:45 AM EDT - 7 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 8:50 AM EDT - 7 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

2025-10-14T11:20:53.000Z - 7 months ago

Sunshine Biopharma allocates $5M for investment in bitcoin

Oct 14, 2025, 7:00 AM EDT - 7 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

2025-10-09T12:26:07.000Z - 7 months ago

Sunshine Biopharma, University of Arizona develop series of protease inhibitors

Oct 9, 2025, 8:00 AM EDT - 7 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

2025-07-02T12:26:57.000Z - 11 months ago

Sunshine Biopharma’s Nora Pharma launches NIOPEG

Jul 2, 2025, 8:00 AM EDT - 11 months ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

2025-06-11T12:40:20.000Z - 1 year ago

Sunshine Biopharma launches generic gabapentin for neuropathic pain

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025, 4:15 PM EDT - 1 year ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

2025-05-06T12:50:59.000Z - 1 year ago

Sunshine Biopharma launches generic Lurasidone for schizophrenia

May 6, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

2025-04-21T12:40:19.000Z - 1 year ago

Sunshine Biopharma launches Everolimus in Canada

Apr 21, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

2025-04-02T12:15:14.000Z - 1 year ago

Sunshine Biopharma announces results from studies on K1.1-mRNA-LNP product

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

2025-04-01T21:15:21.000Z - 1 year ago

Sunshine Biopharma reports FY24 revenue $34.9M vs $24.1M last year

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

2025-03-24T13:06:42.000Z - 1 year ago

Sunshine Biopharma signs agreement for rights to market two generic antibiotics

2025-03-24T12:30:07.000Z - 1 year ago

Sunshine Biopharma in strategic deal for new generic antibiotics in Canada

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

2025-03-10T13:15:30.000Z - 1 year ago

Sunshine Biopharma’s Nora Pharma acquires gastrointestinal drug rights

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Aug 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 19, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Feb 15, 2024, 9:15 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City

Nov 13, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Sep 21, 2023, 9:05 PM EDT - 2 years ago

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Aug 11, 2023, 8:30 AM EDT - 2 years ago

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

May 16, 2023, 2:15 PM EDT - 3 years ago

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

May 16, 2023, 9:58 AM EDT - 3 years ago

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

May 12, 2023, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

May 11, 2023, 9:00 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

Apr 5, 2023, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update

Feb 28, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

Feb 10, 2023, 7:35 AM EST - 3 years ago

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

Jan 19, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Announces Share Repurchase Program

Dec 20, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma's Annual Letter to Shareholders

Dec 5, 2022, 5:46 PM EST - 3 years ago

4 Stocks Meeting GuruFocus' Value Screens in December

RM CACC WFG

Nov 16, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

Masterrunner May. 14 at 12:35 AM

$SBFM Bulls talking this shit up; while it was going to down to oblivion.

0 · Reply

Tabi04 May. 14 at 12:25 AM

$SBFM well it’s right about buying time to play small game.

0 · Reply

hotslots May. 14 at 12:16 AM

$SBFM almost at 50 cents!

0 · Reply

Jimesica May. 13 at 11:45 PM

$SBFM woof, sales went down? WTF, well hopefully the good doctor lives to 120 so we can finally see his work make it to market. Maybe my grandkids will get my original investment back 🤷🏼

1 · Reply

hotslots May. 13 at 11:19 PM

0 · Reply

MB66 May. 13 at 10:07 PM

$SBFM earnings report is out, but chances are they won’t PR the dilution or the earnings report. I don’t even know why there is a board of directors or “management“ at this company.

0 · Reply

MB66 May. 13 at 9:59 PM

$SBFM https://www.sec.gov/ix?doc=/Archives/edgar/data/0001402328/000168316826003819/sunshine_i10q-033126.htm

0 · Reply

MS121 May. 13 at 9:47 PM

$SBFM Please just delist this trash already.

0 · Reply

RonRon1234 May. 13 at 9:46 PM

$SBFM at least we got volume hahahah rofl. Lol. Fuck this is trash.

0 · Reply

Nuisance May. 13 at 9:30 PM

$SBFM pure manipulation https://www.stocktitan.net/sec-filings/SBFM/10-q-sunshine-biopharma-inc-quarterly-earnings-report-286cc9f11cc0.html

0 · Reply

Nuisance May. 13 at 9:26 PM

$SBFM Q1 filing is online

0 · Reply

Animalhouse123 May. 13 at 9:02 PM

$SBFM

0 · Reply

mmwisco May. 13 at 8:57 PM

$SBFM holy smokes. we all know these scumbags screw people over every year, but dam

0 · Reply

Nuisance May. 13 at 8:55 PM

$SBFM Q1 2026 Sales 8m

1 · Reply

samheams May. 13 at 8:51 PM

$SBFM the bargains just keep getting better here! From 51 cents to 51 dollars looks possible here!

0 · Reply

Bigwinner75 May. 13 at 8:46 PM

$SBFM oh lord. What a scam. Lost everything

0 · Reply

Nuisance May. 13 at 8:43 PM

$SBFM https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=320043796&type=HTML&symbol=SBFM&cdn=0529f59834288c092ac2c04da728d4f6&companyName=Sunshine+Biopharma+Inc.&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2026-05-13

0 · Reply

daviso May. 13 at 8:34 PM

$SBFM its as ugly as my prom date. Who is running this shit show?

0 · Reply

hotslots May. 13 at 8:15 PM

$SBFM wow!! Poorhouse city now! Total destruction.

0 · Reply

MB66 May. 13 at 8:09 PM

$SBFM finally seeing some volume up in here! 🤡

0 · Reply

FastMonte May. 13 at 8:04 PM

$SBFM Just imagine if you had invested 2.4mil in 2017 you'd have less than a dollar now. Talk about return for them on your investment 👌

0 · Reply

Kalini67 May. 13 at 8:04 PM

$SBFM Coordinated Short Attack hopefully Soon will be our time to Laugh!

1 · Reply

Market Cap	5.05M
Revenue (ttm)	36.31M
Net Income (ttm)	-5.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-16.47%
Debt to Equity Ratio	0.00

Volume	490,500
Avg Vol	44,538
Day's Range	N/A - N/A
Shares Out	4.91M
Stochastic %K	53%
Beta	1.37
Analysts	Strong Sell
Price Target	$7.00